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Understanding the mechanisms of axonal regeneration and 
improving human recovery after nervous system injury has 
been a long-standing goal of the neuroscience and medical 
community at least since the time of Cajal if not longer. 
Injured peripheral axons mount a robust regenerative 
response, and functional recovery in humans is possible, 
although such recovery is often limited by the long distance 
that regenerating peripheral axons must grow. After central 
nervous system (CNS) injury, axonal regeneration is less suc-
cessful and often only limited recovery is possible. In a series 
of now famous nerve transplantation studies, David and 
Aguayo demonstrated that peripheral nerve grafts support 
robust growth of some central axon populations.1 The initial 
understanding of these experiments emphasized the growth-
inhibitory nature of the CNS environment, and subsequent 
work has elucidated multiple myelin and proteoglycan 
growth-inhibiting components found in the CNS.2 However, 
attempts to improve axonal regeneration and functional 
recovery by ablating these inhibitory molecules by either 
pharmacologic or genetic manipulations have met with only 
minimal (proteoglycan-based inhibitors) or no success (mye-
lin-based inhibitors).3–5 Therefore, a modern interpretation 
of Aguayo and Bray’s famous experiments would suggest 
that the intrinsic growth state varies among neuronal popula-
tions and likely determines the ability of a neuron to either 
overcome an inhibitory environment or avail themselves of a 
growth-permissive environment. Indeed, removal of general, 
growth-suppressing genes notably improves regeneration of 
neuronal populations refractory to regeneration.6
Therefore, in this review we will discuss critical factors 
affecting the ability of injured peripheral and central neu-
rons to generate an effective growth response. We will 
emphasize recent findings that suggest the possibility of 
modulating a neuron’s growth response to injury.
Molecular signaling of axon injury
Calcium
In order to generate a successful response to injury, injured 
axons must first detect axonal damage. Local axonal 
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damage triggers both rapid calcium-based and slower retro-
grade transport-based signals.
Extracellular calcium enters a damaged axon, elevates 
axoplasmic calcium concentration, and may trigger rapid 
growth cone formation in Aplysia.7 Acute axotomy of cul-
tured mammalian neurons also triggers an increase in cal-
cium concentration in the distal tip of the damaged axon. 
Subsequently, a calcium wave is retrogradely propagated to 
the soma by voltage-dependent sodium channel activation 
of a transient calcium current.8 Calcium transients also   
correlate with regenerative growth and this growth depends, 
in part, on a dual leucine kinase-1 (DLK-1), a conserved 
member of the mitogen-activated protein kinase (MAPK) 
pathway, in Caenorhabditis elegans.9 This kinase has also 
been found to be required for growth cone formation and 
regeneration throughout the C. elegans life cycle10 and in 
drosophila.11 In mice, depletion of DLK-1 sensory neuron 
outgrowth in vitro and phosphorylation of c-jun in vivo are 
reduced.12 The effect of DLK-1 may be mediated by 
enhancement of CCAAT/enhancer-binding protein-1 (C/
EBP-1) mRNA stability.13 Calcium, therefore, quickly sig-
nals acute axonal injury and, in part, initiates a regenera-
tive response through DLK-1.
Retrograde signals of axonal injury
In addition to the calcium-generated injury response, 
slower, retrogradely transported proteins also signal 
axonal injury to the cell body. Best characterized of these 
molecules are the importins. After injury, local axonal 
synthesis of β1-importin allows assembly of a macromo-
lecular complex and retrograde transport of nuclear local-
ization sequence (NLS)-containing cargo to the nucleus of 
sensory neurons. Excess exogenous NLS peptide slows 
regenerative growth.14 Multiple importin-binding cargos 
have been identified, but in neurons, translocation of 
vimentin-bound MAP kinase extracellular signal-regu-
lated kinase (ERK)15 and the transcription factor CREB216 
clearly suggest retrograde transported cargo signal injury 
to the cell body. At least in sensory neurons, the initiation 
and loading of cargo appear dependent on axonal Ran-
binding protein 1 (RanBP1).17 Other possible signals 
include Smads, which are also regulated after peripheral 
nerve injury.18,19 At least one, Smad1, appears important 
for initiation or maintenance of sensory neurite out-
growth.18 Wallenda, the drosophila homologue of DLK, is 
required for injury signaling and is regulated by an E3 
ubiquitin ligase highwire.11 Retrograde transport of a 
c-Jun NH2-terminal kinase (JNK) scaffolding protein, 
Sunday Driver,20 multiple JNK signaling molecules, and 
ATF3 have also been observed.21 Given the observed vari-
able growth competence of CNS and peripheral nervous 
system (PNS) neurons to regenerate, it is possible that 
neuronal populations signal damage with differing effi-
cacy. Nonetheless, it is clear that retrograde signals 
participate in signaling axonal damage and aid initiation 
of a growth response.
Neuronal cell death and regeneration
In order to regenerate, a neuron must survive the severing 
of its axon. During development, axotomy has been clearly 
linked to cell death. However, in the adult CNS, survival 
and regeneration appear distinct. After optic nerve axot-
omy, many retinal ganglion neurons survive axotomy if a 
peripheral nerve graft is placed near the neurons. However, 
only a small number of these surviving neurons regenerate 
into the graft.22 In addition, overexpression of bcl-2,   
an antiapoptotic gene, in retinal ganglion cells (RGCs) 
improves survival but does not substantially increase axon 
growth into a peripheral nerve graft.23 Thus, although neu-
ronal survival is a necessary prerequisite for regeneration, 
survival itself does not confer a neuron with the ability to 
regenerate.
Extrinsic modulation of the neuronal 
growth response
The intrinsic growth capacity of an injured neuron is 
largely influenced by the external environment. Some   
of the important extrinsic signals are presented in the fol-
lowing sections, and intrinsic drivers of regeneration are 
considered next.
Cytokines
After axonal injury in vivo, the inflammatory environment 
contributes substantially to the neuronal injury response. 
Local inflammation near central or peripheral neuronal cell 
bodies elicits improved axonal growth, as first demon-
strated by injecting either Cornyebacterium or activated 
macrophages into lumbar sensory neurons and measuring 
axonal regeneration after dorsal root crush.24 Macrophages 
also appear to play a similar key role in augmentation of 
CNS axonal growth. After injury of the optic nerve, mac-
rophage-derived oncomodulin produced following the 
injection of zymosan or after lens injury promotes RGC 
regeneration.25–27 In addition, ciliary neurotrophic factor 
(CNTF) and leukemia inhibitory factor (LIF) are likely 
important in the retinal ganglion cell injury response as 
CNTF and LIF null animals failed to regenerate optic nerve 
axons after combined optic nerve crush and lens injury.28 
Despite this observation, purified, exogenous cytokines 
only moderately improve CNS regeneration.29,30 Recent 
important experiments have provided a possible explana-
tion for these observations. In particular, suppressor of 
cytokine signaling (SOCS) proteins may importantly limit 
the effectiveness of endogenous and exogenous cytokines 
in stimulating CNS regeneration. SOCS proteins are cyto-
plasmic inhibitors of JAK-STAT signaling.31,32 Regeneration Ferguson TA and Son Y-J  3
was markedly improved using viral-mediated delivery of 
Cre (Cre recombinase) to the retina of SOCS3fl/fl mice prior 
to optic nerve crush.33 The successful regeneration corre-
lated with a reversal of mTOR pathway activity. Concurrent 
deletion of gp130 and SOCS3 also abrogated successful 
regeneration, suggesting that cytokine-mediated gp130 
activation is required. Furthermore, STAT3 phosphoryla-
tion was severely decreased in these animals. Finally, viral-
mediated overexpression of SOCS3 abrogates optic axon 
regeneration into a peripheral nerve graft.34 Together these 
observations suggest that CNTF and LIF may successfully 
initiate axonal regeneration in RGCs if the JAK-STAT sign-
aling cascade is suitably activated. Likewise in sensory 
neurons, SOCS3 overexpression inhibits neurite outgrowth, 
at least in part, through inhibition of STAT3 signaling.35 
Thus, while inflammation may clearly promote regenera-
tion under certain circumstances, this response is also cur-
tailed by neuronal expression of SOCS proteins, and in 
certain CNS neurons, this suppression may be powerful 
enough to limit regenerative growth.
Neurotrophins
Neurotrophins and neurotrophic factors critically regulate 
the developmental cell survival and differentiation. In vitro, 
exogenous neurotrophin application increases axon growth 
of multiple neuron types.36 However, the in vivo role of 
individual neurotrophins in regeneration is less clear and 
likely complex. After peripheral nerve injury, Schwann cell 
production of multiple neurotrophins dramatically increases 
and is thought to be important for regeneration.37 Importantly, 
elevated levels of neurotrophins do not persist in chronic 
axotomy.38 In agreement with this observation, addition of 
exogenous brain-derived neurotrophic factor (BDNF) or 
glial-cell derived neurotrophic factor (GDNF) after acute or 
chronic sciatic nerve injury increased axon sprout formation 
at the injury site but did not increase the number of success-
fully regenerated motor neurons.39,40 However, exogenous 
administration of either BDNF or GDNF after chronic 
injury did improve motor axon regeneration.39,40 Therefore, 
neurotrophin-dependent axon sprout formation after injury 
may not necessarily equate to successful regeneration and 
only in certain circumstances are BDNF and GDNF impor-
tant for peripheral axonal regeneration.
In multiple studies, exogenous neurotrophins delivered 
to the injured CNS have demonstrated increased axon 
growth.41 However, in these studies, either regeneration of 
axons has been modest42 or distinguishing long-distance 
axonal regeneration from sprouting of uninjured axons has 
been difficult. Most impressive have been studies of neu-
rotrophin application after dorsal root crush. After crush 
injury, dorsal root axons regenerate within the peripheral 
nerve root but stall shortly after entering the CNS, perhaps 
because of rapid presynaptic differentiation at the CNS/
PNS border.43 However, on intrathecal application of nerve 
growth factor (NGF), neurotrophin-3 (NT-3), or GDNF, 
dorsal root axons reinnervated the dorsal horn and partially 
reestablished sensory function.44 Similarly, systemic arte-
min not only allowed dorsal root ganglion (DRG) axon 
growth across the dorsal root entry zone but also restored 
both nociceptive and sensorimotor function.45 Furthermore, 
after artemin administration (but not Nogo receptor block-
ade), DRG axons regenerated to topographically appropri-
ate region of the spinal cord dorsal horn.46 BDNF was not 
effective in this model. These observations suggest exog-
enous neurotrophins may be useful in promoting func-
tional recovery after injury of DRG central processes. 
However, addition of exogenous neurotrophins does not 
define a biologic role for these molecules, which is likely 
complex and dependent on cell type. For example, cell-
specific deletion of TrkB, the cognate BDNF receptor, 
from retina demonstrated that a model of toxic injury loss 
of TrkB from glial cells was as deleterious as loss of TrkB 
from neurons. Therefore, TrkB signaling in glial cells may 
be as important for RGC protection as neuronal TrkB sign-
aling. Furthermore, loss of TrkB signaling in glial cells 
impaired glial proliferation and dedifferentiation after 
toxic insult.47 Clearly, defining both the biologic and pos-
sible therapeutic roles for neurotrophins in regeneration 
will require carefully designed experiments that address 
the functions of neurotrophins and their receptors within 
both neurons and glial cells.
Glia-associated growth inhibitors
Experiments of the last two decades have well characterized 
exogenous neuronal growth inhibitors and recent reviews 
exist.2 Of these, the best described extrinsic growth-inhibi-
tory molecules include the following: myelin-associated 
glycoprotein (MAG),48,49 Nogo,50–52 and oligodendrocyte-
myelin glycoprotein (OMgp).53,54 These molecules are syn-
thesized by oligodendrocytes and distributed in the myelin 
ensheathing CNS axons. All three myelin inhibitors bind to 
the glycosylphosphatidylinositol-anchored Nogo-66 recep-
tor (NgR1), which is expressed by many CNS neurons.54–56 
NgR1 antagonist treatment enhanced neurite outgrowth 
from DRG cells in co-culture model. Other receptors have 
also been implicated in mediating the inhibitory effect, 
including NgR2 and the paired immunoglobulin-like recep-
tor B (PirB).57,58
The other major group molecules that inhibit neural 
regeneration are the chondroitin sulfate proteoglycan 
(CSPG) inhibitors. Chondroitin 6-sulfate proteoglycans 
are produced by astrocytes and associated with glial scar, 
which plays a major role in the regenerative failure after 
CNS injury.59–61 Neuroglycan 2 (NG2), aggrecan, brevi-
can, neurocan, vesicant, and phosphacan are all different 
members of CSPG family of extracellular matrix mole-
cules.62 The inhibitory property of CSPG has been attrib-
uted to its glycosaminoglycan (GAG) side chains, and 4  Journal of Tissue Engineering 2(1)
enzymatic removal of GAG chains by chondroitinase ABC 
(ChABC) has been shown to promote axon regeneration 
both in vitro and in vivo.3,63–66 Recently, a transmembrane 
protein tyrosine phosphatase, PTPσ, was identified as a 
high-affinity receptor of CSPG, which mediates its inhibi-
tory effect.67 Despite convincing in vitro data on the role of 
these growth-inhibitory molecules, knockout of the three 
myelin inhibitory proteins,4 or the NgR,68 has not improved 
corticospinal tract axonal regeneration. Enzymatic removal 
of CSPG or genetic deletion of PTPσ3,69 modestly improved 
axonal growth, although it is unclear if the observed 
growth is long-tract axonal regeneration or sprouting of 
spared axons. Thus, while the myelin and proteoglycan 
inhibitory molecules play some role in limiting axonal 
growth, additional limitations on axonal regenerative 
growth likely exist.
Intrinsic modulation of neuronal 
growth response
Endogenous growth suppressors
Discouraged by the poor regeneration observed after 
removal of myelin-based extrinsic growth inhibitors, inves-
tigators have attempted to define endogenous inhibitors of 
axonal regeneration. Early successes have focused on the 
molecule phosphatase and tensin homologue (PTEN) 
deleted on chromosome 10. Originally discovered as a 
tumor suppressor,7 PTEN deletion has been recently shown 
to dramatically increase postembryonic regeneration after 
injury in RGCs and corticospinal neurons in the CNS70,71 
and axon outgrowth in the PNS.72 Loss of PTEN likely 
results in phosphatidylinositol (3,4,5)-trisphosphate (PIP3) 
accumulation, deregulation of AKT signaling, and likely 
increases regeneration through multiple downstream sign-
aling effectors (for recent review see Ref. 6). Of particular 
note, administration of rapamycin (a known inhibitor of the 
mTOR pathway) significantly impaired PTEN deletion–
mediated regeneration6 and, additionally, deletion of the 
endogenous mTOR inhibitor; tuberous sclerosis complex-1 
(TSC1) also increased regeneration after optic nerve 
crush.70 These important observations suggest that the 
impressive CNS regeneration observed in these experi-
ments depends, at least in part, on the ability of the neuron 
to initiate new protein synthesis needed to manufacture the 
raw material required for axonal regeneration. However, 
TSC-deleted regeneration was not as robust as PTEN-
mediated regeneration suggesting some importance of 
signaling not dependent on new protein synthesis. Despite 
the substantial growth observed with PTEN deletion, 
regenerating axons did not reach the lateral geniculate. At 
least in RGCs, true target reinnervation will likely only 
result with combinatorial treatments including PTEN dele-
tion, activation of inflammation, and elevation of cyclic 
adenosine monophosphate (cAMP).73
Also downstream from PTEN but likely independent of 
the mTOR pathway, glycogen synthesis kinase (GSK) also 
importantly regulates axon growth. Pharmacological PTEN 
inhibition increases phospho-AKT (pAKT) and pGSK-3β 
levels and neurite outgrowth suggesting one effector of 
PTEN inhibition–mediated outgrowth is GSK-3β.74 GSK-3 
integrates multiple extracellular signals to modulate axon 
formation and elongation both at the cell body and growth 
cone.6 Neurotrophin-dependent inactivation of GSK-3β 
increases adenomatous polyposis coli (APC)75 or collapsin 
response mediator protein-2 (CRMP-2)76 stabilization of 
microtubules and increases axon elongation in developing 
neurites. Interestingly, basal GSK-3β activity likely pre-
vents ongoing axon formation.77 More recent data suggest 
that GSK-3β likely plays a similar role in adult neurons78,79 
and pharmacologic inhibition may improve raphespinal 
and corticospinal growth after spinal cord injury.80 
However, GSK-3β may also respond to myelin inhibitors 
and, therefore, may regulate growth in a more complex 
fashion.81
Cyclic nucleotides
Loss of neuronal cAMP, in part, accounts for developmen-
tal loss of regenerative ability,82 and spinal cord injury 
results in reduction of neuronal cAMP levels.83 Raising 
cAMP levels in a poorly regenerating zebrafish axons 
improved regeneration.84 Exogenous db-cAMP injection 
into dorsal root ganglia improves axonal growth into a spi-
nal cord lesion,85 and local injection of a phosphodiesterase 
inhibitor (which elevates cAMP levels) improves axonal 
regeneration and functional recovery after spinal cord 
injury86 or regeneration after peripheral nerve injury.87 It is 
unclear if cAMP’s salutary effect on in vivo axon growth 
occurs at the axon tip, cell body, or both. Certainly, the 
effects of growth inhibitors at the growth cone are depend-
ent on the neuronal levels of cAMP. When levels are high, 
the effect on the growth cone is chemoattraction, whereas 
when they are low, the effect is chemorepulsion,88–90 but 
the importance of these observations in regeneration is not 
clear. Interestingly, regeneration of spinal axons of lamprey 
is accelerated by exogenous cAMP, even though these 
axons do not appear to have classic growth cones.91
In regenerating zebrafish axons, cAMP dependent–
regeneration required DLK-1 kinase.9 Moreover, cAMP 
modulates expression of SOCS molecules in the retina, 
which are known to limit cytokine-induced growth, and 
may provide an additional mechanism by which cyclic 
nucleotides augment regeneration.92 These studies suggest 
that cAMP prepares the neuron for a regenerative response.
Transcription factors
In response to injury, some neurons dramatically alter their 
patterns of gene expression and switch to a regenerative Ferguson TA and Son Y-J  5
phenotype, whereas other neuronal populations do not   
substantially alter their gene expression or abort an early 
regenerative response and thus fail to regenerate an axon. 
The coordinate regulation of these responses is likely   
controlled by multiple transcription factors and recent 
experiments have begun to elucidate both the basis of a suc-
cessful regenerative phenotype after injury and the con-
comitant loss of regenerative ability that often occurs 
developmentally in CNS axons.
A study of developmentally regulated RGC genes 
revealed that multiple members of the Krüppel-like factors 
(KLFs) are present and developmentally regulated in RGCs 
and, therefore, putative regulators of axon growth.93 KLFs 
are a family of zinc-finger-containing transcription factors 
that regulate diverse biological processes.94 KLF-4 and 
KLF-9 expression increase at birth but KLF-6 and KLF-7 
decrease, suggesting that these molecules may control the 
growth potential of retinal ganglion neurons. Indeed, dele-
tion of KLF-4 improves neurite growth in vitro and optic 
nerve regeneration after crush in vivo.93 In addition, optic 
axons successfully regenerate in adult zebrafish and increase 
their expression of KLF6a and KLF7a after injury. 
Furthermore, simultaneous knockdown of both these mole-
cules impaired RGC outgrowth.95 Interestingly, KLF knock-
down impaired regeneration-dependent expression of alpha 
1 tubulin, which is likely important for axon extension.96 
These observations demonstrate that the regenerative com-
petence of neurons is actively regulated by groups of func-
tionally interrelated transcription factors but during 
development and after injury. Furthermore, manipulation of 
these factors can improve neuronal regenerative potential.
However, it is likely that the complex control of the 
regenerative response is an ‘all or none’ phenomenon, but 
instead discrete aspects of regeneration are likely controlled 
by separate transcription factors. STAT3, as part of the 
JAK-STAT signaling pathway, is activated after peripheral 
but not central axon lesion97 and pharmaceutical blockade 
of STAT3 activation after peripheral nerve injury prevents 
CNS axon growth normally observed after a conditioning 
lesion.98 These observations suggest that STAT3 plays a 
critical role in the neuronal response to injury. However, 
recent experiments have importantly refined the role of 
STAT3 in regeneration. After selective deletion of sensory 
neuron STAT3, the initiation of peripheral regeneration 
after nerve transection stalled but subsequent axonal elon-
gation was unaffected. In addition, STAT3 overexpression 
in DRGs increased sprout formation after dorsal column 
lesion but did not lead to persistent axonal growth.99 Finally, 
STAT3 overexpression also increased neurite outgrowth   
of cerebellar granule cells in vitro.100 Therefore, STAT3 
importantly regulates the initiation but not continuation of 
axonal regeneration in both central and peripheral axons. In 
general, these observations suggest that individual signal-
ing pathways and downstream transcription factors may 
control discrete phases of the regenerative process.
Interestingly, some transcription factors increase after 
injury but appear to limit the regeneration response. Nuclear 
factor IL-3 (NFIL3) regulation increases in sensory neu-
rons after injury but represses CREB-mediated transcrip-
tion and expression of regeneration-associated genes such 
as arginase and GAP-43, thereby likely limiting the regen-
erative response.101 More recently, NFIL3 has been shown 
to also repress expression of genes activated by C/EBP 
family members.102 Therefore, even successfully regenerat-
ing neurons may endogenously limit their growth response.
Other notable transcription factors include members   
of the Jun and Fos families, components of the transcrip-
tion factor AP-1 and ATF3. Cre-mediated c-jun deletion in 
the CNS impaired regeneration of facial motor axons, 
abrogated upregulation of several other regeneration- 
associated molecules, and impaired microglial activa-
tion.103 ATF3 increases after peripheral nerve axotomy in 
motor and sensory neurons.104 Expression may also be 
seen in corticospinal neurons with intracortical but not spi-
nal cord lesions,105 thalamic nuclei that have grown into a 
peripheral nerve graft,106 or zebrafish retina, which can 
successfully regenerate axons.107 Transgenic overexpres-
sion of ATF3 in dorsal root ganglia increased the regenera-
tive capacity of peripheral DRG axons suggesting ATF3 
expression may help determine the regenerative state of 
sensory neurons.108
Effectors of axonal regeneration
After injury in the CNS, cut axons may attempt to regener-
ate. However, despite these attempts, damaged axons do 
not regenerate to significant distances. Axonal growth fail-
ure is a result of both the neuron’s poor intrinsic growth 
potential and the growth-inhibitory environment of the 
injured CNS. Recent studies of intrinsic growth regulators 
have emphasized the importance of new protein synthesis 
and axonal transport as critical determinants of regenera-
tion, and other studies have emphasized regeneration-asso-
ciated molecules that correlate with successful regeneration. 
Therefore, the many growth-associated molecules that are 
regulated by intrinsic determinants of regeneration likely 
play a critical and specific role in the regenerative process 
and some are highlighted in the following sections.
Conditioning lesions
If a cut regenerating axon is reinjured more proximally, it 
will grow at a greater rate than if the axon suffered only one 
injury. This is the classic conditioning lesion.109 Most 
remarkably, sciatic nerve transection prior to a dorsal col-
umn lesion of the ascending sensory neuron projections 
remarkably improved regeneration within the injured 
CNS.110 Subsequent studies found a substantial increase   
in cAMP in injured DRG and that db-cAMP injections 6  Journal of Tissue Engineering 2(1)
partially replicate the effect of a conditioning lesion.85 
Interestingly, interleukin (IL)-6 injections also mimic this 
response but IL-6 is not required for a conditioning lesion 
effect.111 More recent experiments have found that cultured 
superior cervical ganglia neurons did not respond to condi-
tioning lesion if gp130 was deleted.112 One downstream 
effect of a conditioning lesion is increased transport of 
tubulin and actin.113 However, in poorly regenerating 
RGCs, axonal transport of cytoskeleton proteins decreases 
10-fold unless axons encounter and regenerate into a 
peripheral nerve grafts.114,115 Although not fully under-
stood, the improved regeneration observed after condition-
ing lesion most importantly emphasizes the critical role that 
neuronal growth state plays in successful regeneration, 
even in the injured CNS and further suggests that associ-
ated differences in axonal transport may play a role in 
growth efficacy.
Growth-associated proteins
After sciatic nerve transection, at least an estimated 240 
genes in DRG undergo dramatic up or down regulation,116 
including a number of transcription factors that undergo 
early change after injury.117 Presumably, this coordinated 
response regulates genes critical for conversion of a neuron 
to a growth-promoting phenotype and, therefore, success-
ful axonal regeneration. Of these growth-associated genes, 
GAP-43 is best known, although its precise function is 
unclear.118,119 Cell type–specific overexpression of GAP-43 
in transgenic mice did not induce axonal regeneration in 
these cells, although short-distance sprouting did occur. 
These findings can be interpreted to imply that GAP-43 is 
important in the generation of growth cones but this is not 
sufficient to induce regeneration. However, when GAP-43 
and cytoskeleton-associated protein of 23 kDa (CAP-23) 
were overexpressed together, DRG axons were able to 
regenerate after spinal cord transection.120 In transgenic 
zebrafish, a GAP-43 promoter element that triggered 
expression of GAP-43 during axon development did not do 
so during regeneration of optic nerve.121 Thus, the signaling 
pathways for axon elongation during regeneration may be 
different from those during axon development.
Cytoskeletal proteins
During development, growth cones are found at the growing 
tips of axons and consist of filopodia and lamellipodia. 
Embedded in these structures are cell surface receptors that 
translate surface binding into the intracellular signals that 
regulate axon elongation, turning, and growth inhibition. 
The role of cytoskeletal elements in adult neuron regenera-
tion is less clear, although presumably important. During 
CNS regeneration in mammals, growth cones are poorly 
formed, with a bullet-like appearance and dystrophic axon 
retraction bulbs are commonly observed. During peripheral 
nerve regeneration, synthesis of tubulin and actin is 
increased but neurofilament is downregulated122 suggesting 
that microtubules and actin microfilaments are critical for 
regeneration. Importantly, in the CNS, only axons regener-
ating into a peripheral nerve graft express tubulin,123 sug-
gesting that the CNS environment may limit the expression 
of cytoskeletal elements important for axon extension. In a 
morphologic analysis of regenerating axons, Ertuk and col-
leagues found that microtubules in retraction bulbs were not 
arrayed along the longitudinal axis of the axon in contrast to 
axons without retraction bulbs. Local administration of 
taxol, a microtubule-stabilizing agent, interfered with retrac-
tion bulb formation after dorsal column lesion and increased 
in vitro neurite outgrowth on myelin.124 After optic nerve 
crush, local taxol administration in combination with lens 
injury notably increased axon growth, perhaps through 
reduction of local CSPG production.125 Similarly, after 
peripheral conditioning and dorsal column lesions, sensory 
axons grew into glial scar after local taxol administration 
possibly because of decreased TGF-β1 signaling and   
CSPG production.126 Surprisingly, regenerative axon elon-
gation does not appear to require a microtubule-organizing 
center.127 Thus, it may be that microtubules (MTs) assem-
bled locally in a growing axon and are important for regen-
eration and responsive to local inhibitory molecules.
Cell adhesion molecules
In the CNS and PNS, regenerating axons often grow on cell 
surfaces.71,128–130 In the PNS, cell adhesion molecules 
embedded in the Schwann cell membrane are thought to 
contribute to the success of regeneration, whereas in the 
injured CNS, the cellular environment and their respective 
cell adhesion molecules are a complex mix of growth-
inhibitory and growth-promoting molecules, which, on bal-
ance, are thought to impede regeneration.2,130 The molecules 
of the Schwann cell membrane are thought to facilitate 
axonal regeneration that includes neuronal cadherin 
(NCAD) and L1, among others.131–134 NCAD, L1, and neu-
ronal cell adhesion molecule (NCAM) are thought to be 
important for embryonic neurite growth on astrocytes in the 
CNS.135–137 After injury, adult PNS neurons and glia 
increase expression of these growth-associated cell adhe-
sion molecules,138–140 but in the CNS, poorly regenerating 
neurons such as RGCs or corticospinal neurons do not 
reexpress these molecules after injury.141,142 In zebrafish, 
the regenerative abilities of different neurons correlated 
with expression of the homophilic cell adhesion molecule 
L1 and NCAD.143,144 Furthermore, L1 knockdown in motor 
neurons impaired axonal regeneration.145 Thus, adhesion 
molecules are able to help overcome an inhibitory environ-
ment and tip the balance to favor axon regeneration. 
Following this logic, forced expression of cell adhesion 
molecules improves CNS recovery after injury. For exam-
ple, increased L1 or L1 and GAP-43 expression improved Ferguson TA and Son Y-J  7
Purkinje cell regeneration into a peripheral nerve graft,146 
and virally mediated L1 expression at the site of spinal cord 
injury stabilized the corticospinal tract, enhanced the 
growth of 5-HT axons, and correlated with moderate func-
tional improvement.147 In conclusion, earlier reports dem-
onstrated that after spinal cord injury in adult rats, treatment 
with soluble L1-Fc promotes axon regeneration and func-
tional recovery.148 Therefore, the ability of neurons to 
express complimentary cell adhesion molecules on their 
surface is likely one important intrinsic determinant of their 
regenerative ability.
Summary and conclusions
The injured human CNS has only limited ability to recover 
after injury and little of this recovery appears to correlate 
with true, long-distance axonal regeneration. Studies care-
fully delineating the multiplicity of glial-inhibitory mole-
cules and their axonal receptors generated widespread 
enthusiasm that removal of these molecules would improve 
both recovery and long-distance axonal regeneration. 
However, such removal does not appear to have had a dra-
matic effect on either functional recovery or long-distance 
axonal regeneration. More recent experiments suggest that 
robust long-distance regeneration potential declines devel-
opmentally and may be further suppressed after injury. 
Strikingly, removal of an array of growth suppressor   
molecules allows robust, long-distance axonal growth,   
presumptively by activating a regenerative response not 
normally accessible to most injured CNS neurons. These 
observations again provide hope that rational manipulation 
of the injured CNS will provide successful treatments after 
CNS injury. However, given the inherent glial and neuronal 
complexity of the injured CNS, it is unlikely that a single 
treatment approach will repair the CNS after injury. Instead, 
combination treatments will be increasingly prominent and 
indeed have shown promise experimentally.73
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